EMEA (Europe, Middle East and Africa) Carbetocin (Duratocin) Market Report 2018

January 2018 | 110 pages | ID: E3A52294403EN
QYResearch

Abstracts

In this report, the EMEA Carbetocin (Duratocin) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Carbetocin (Duratocin) for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Carbetocin (Duratocin) market competition by top manufacturers/players, with Carbetocin (Duratocin) sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Beacon Pharmaceuticals Limited
• Ferring Inc.
• Polypeptide Laboraries France
• Chemos GmbH & Co. KG
• Hangzhou Dayangchem Co. Ltd.
• Acinopeptide Co., Ltd.
• Bachem AG
• Clearsynth Canada INC.
• Leap Labchem Co., Ltd
• Chemieliva Pharmaceutical Co., Ltd.
• Acinopeptide Co., Ltd.
• BOC Sciences

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Tablets
• Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Oxytocic
• Antihemorrhagic
• Uterotonic

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Carbetocin (Duratocin) Market Report 2017

1 CARBETOCIN (DURATOCIN) OVERVIEW

1.1 Product Overview and Scope of Carbetocin (Duratocin)
1.2 Classification of Carbetocin (Duratocin)
  1.2.1 EMEA Carbetocin (Duratocin) Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Carbetocin (Duratocin) Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Tablets
  1.2.4 Injection
1.3 EMEA Carbetocin (Duratocin) Market by Application/End Users
  1.3.1 EMEA Carbetocin (Duratocin) Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Oxytocic
  1.3.3 Antihemorrhagic
  1.3.4 Uterotonic
1.4 EMEA Carbetocin (Duratocin) Market by Region
  1.4.1 EMEA Carbetocin (Duratocin) Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Carbetocin (Duratocin) (2012-2022)
  1.5.1 EMEA Carbetocin (Duratocin) Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Carbetocin (Duratocin) Revenue and Growth Rate (2012-2022)

2 EMEA CARBETOCIN (DURATOCIN) COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Carbetocin (Duratocin) Market Competition by Players/Manufacturers
  2.1.1 EMEA Carbetocin (Duratocin) Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Carbetocin (Duratocin) Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Carbetocin (Duratocin) Sale Price by Players (2012-2017)
2.2 EMEA Carbetocin (Duratocin) (Volume and Value) by Type/Product Category
  2.2.1 EMEA Carbetocin (Duratocin) Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Carbetocin (Duratocin) Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Carbetocin (Duratocin) Sale Price by Type (2012-2017)
2.3 EMEA Carbetocin (Duratocin) (Volume) by Application
2.4 EMEA Carbetocin (Duratocin) (Volume and Value) by Region
  2.4.1 EMEA Carbetocin (Duratocin) Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Carbetocin (Duratocin) Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Carbetocin (Duratocin) Sales Price by Region (2012-2017)

3 EUROPE CARBETOCIN (DURATOCIN) (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Carbetocin (Duratocin) Sales and Value (2012-2017)
  3.1.1 Europe Carbetocin (Duratocin) Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Carbetocin (Duratocin) Revenue and Growth Rate (2012-2017)
3.2 Europe Carbetocin (Duratocin) Sales and Market Share by Type
3.3 Europe Carbetocin (Duratocin) Sales and Market Share by Application
3.4 Europe Carbetocin (Duratocin) Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Carbetocin (Duratocin) Sales Volume by Countries (2012-2017)
  3.4.2 Europe Carbetocin (Duratocin) Revenue by Countries (2012-2017)
  3.4.3 Germany Carbetocin (Duratocin) Sales and Growth Rate (2012-2017)
  3.4.4 France Carbetocin (Duratocin) Sales and Growth Rate (2012-2017)
  3.4.5 UK Carbetocin (Duratocin) Sales and Growth Rate (2012-2017)
  3.4.6 Russia Carbetocin (Duratocin) Sales and Growth Rate (2012-2017)
  3.4.7 Italy Carbetocin (Duratocin) Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Carbetocin (Duratocin) Sales and Growth Rate (2012-2017)

4 MIDDLE EAST CARBETOCIN (DURATOCIN) (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Carbetocin (Duratocin) Sales and Value (2012-2017)
  4.1.1 Middle East Carbetocin (Duratocin) Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Carbetocin (Duratocin) Revenue and Growth Rate (2012-2017)
4.2 Middle East Carbetocin (Duratocin) Sales and Market Share by Type
4.3 Middle East Carbetocin (Duratocin) Sales and Market Share by Application
4.4 Middle East Carbetocin (Duratocin) Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Carbetocin (Duratocin) Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Carbetocin (Duratocin) Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Carbetocin (Duratocin) Sales and Growth Rate (2012-2017)
  4.4.4 Israel Carbetocin (Duratocin) Sales and Growth Rate (2012-2017)
  4.4.5 UAE Carbetocin (Duratocin) Sales and Growth Rate (2012-2017)
  4.4.6 Iran Carbetocin (Duratocin) Sales and Growth Rate (2012-2017)

5 AFRICA CARBETOCIN (DURATOCIN) (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Carbetocin (Duratocin) Sales and Value (2012-2017)
  5.1.1 Africa Carbetocin (Duratocin) Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Carbetocin (Duratocin) Revenue and Growth Rate (2012-2017)
5.2 Africa Carbetocin (Duratocin) Sales and Market Share by Type
5.3 Africa Carbetocin (Duratocin) Sales and Market Share by Application
5.4 Africa Carbetocin (Duratocin) Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Carbetocin (Duratocin) Sales Volume by Countries (2012-2017)
  5.4.2 Africa Carbetocin (Duratocin) Revenue by Countries (2012-2017)
  5.4.3 South Africa Carbetocin (Duratocin) Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Carbetocin (Duratocin) Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Carbetocin (Duratocin) Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Carbetocin (Duratocin) Sales and Growth Rate (2012-2017)

6 EMEA CARBETOCIN (DURATOCIN) MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Beacon Pharmaceuticals Limited
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Carbetocin (Duratocin) Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Ferring Inc.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Carbetocin (Duratocin) Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Ferring Inc. Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Polypeptide Laboraries France
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Carbetocin (Duratocin) Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Polypeptide Laboraries France Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Chemos GmbH & Co. KG
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Carbetocin (Duratocin) Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Hangzhou Dayangchem Co. Ltd.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Carbetocin (Duratocin) Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Acinopeptide Co., Ltd.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Carbetocin (Duratocin) Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Bachem AG
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Carbetocin (Duratocin) Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Bachem AG Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Clearsynth Canada INC.
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Carbetocin (Duratocin) Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Clearsynth Canada INC. Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Leap Labchem Co., Ltd
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Carbetocin (Duratocin) Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Chemieliva Pharmaceutical Co., Ltd.
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Carbetocin (Duratocin) Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Acinopeptide Co., Ltd.
6.12 BOC Sciences

7 CARBETOCIN (DURATOCIN) MANUFACTURING COST ANALYSIS

7.1 Carbetocin (Duratocin) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Carbetocin (Duratocin)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Carbetocin (Duratocin) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Carbetocin (Duratocin) Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA CARBETOCIN (DURATOCIN) MARKET FORECAST (2017-2022)

11.1 EMEA Carbetocin (Duratocin) Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Carbetocin (Duratocin) Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Carbetocin (Duratocin) Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Carbetocin (Duratocin) Price and Trend Forecast (2017-2022)
11.2 EMEA Carbetocin (Duratocin) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Carbetocin (Duratocin) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Carbetocin (Duratocin) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Carbetocin (Duratocin) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Carbetocin (Duratocin) Sales Forecast by Type (2017-2022)
11.7 EMEA Carbetocin (Duratocin) Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Carbetocin (Duratocin)
Figure EMEA Carbetocin (Duratocin) Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Carbetocin (Duratocin) Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablets Product Picture
Figure Injection Product Picture
Figure EMEA Carbetocin (Duratocin) Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Carbetocin (Duratocin) by Application in 2016
Figure Oxytocic Examples
Table Key Downstream Customer in Oxytocic
Figure Antihemorrhagic Examples
Table Key Downstream Customer in Antihemorrhagic
Figure Uterotonic Examples
Table Key Downstream Customer in Uterotonic
Figure EMEA Carbetocin (Duratocin) Market Size (Million USD) by Region (2012-2022)
Figure Europe Carbetocin (Duratocin) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Carbetocin (Duratocin) Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Carbetocin (Duratocin) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Carbetocin (Duratocin) Revenue (Million USD) Status and Forecast by Countries
Figure Africa Carbetocin (Duratocin) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Carbetocin (Duratocin) Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Carbetocin (Duratocin) Sales Volume and Growth Rate (2012-2022)
Figure EMEA Carbetocin (Duratocin) Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Carbetocin (Duratocin) Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Carbetocin (Duratocin) Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Carbetocin (Duratocin) Sales Share by Players (2012-2017)
Figure 2016 Carbetocin (Duratocin) Sales Share by Players
Figure 2017 Carbetocin (Duratocin) Sales Share by Players
Figure EMEA Carbetocin (Duratocin) Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Carbetocin (Duratocin) Revenue (Million USD) by Players (2012-2017)
Table EMEA Carbetocin (Duratocin) Revenue Share by Players (2012-2017)
Table 2016 EMEA Carbetocin (Duratocin) Revenue Share by Players
Table 2017 EMEA Carbetocin (Duratocin) Revenue Share by Players
Table EMEA Carbetocin (Duratocin) Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Carbetocin (Duratocin) Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Carbetocin (Duratocin) Sales Share by Type (2012-2017)
Figure Sales Market Share of Carbetocin (Duratocin) by Type (2012-2017)
Figure EMEA Carbetocin (Duratocin) Sales Market Share by Type (2012-2017)
Table EMEA Carbetocin (Duratocin) Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Carbetocin (Duratocin) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Carbetocin (Duratocin) by Type in 2016
Table EMEA Carbetocin (Duratocin) Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Carbetocin (Duratocin) Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Carbetocin (Duratocin) Sales Share by Application (2012-2017)
Figure Sales Market Share of Carbetocin (Duratocin) by Application (2012-2017)
Figure EMEA Carbetocin (Duratocin) Sales Market Share by Application in 2016
Table EMEA Carbetocin (Duratocin) Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Carbetocin (Duratocin) Sales Share by Region (2012-2017)
Figure Sales Market Share of Carbetocin (Duratocin) by Region (2012-2017)
Figure EMEA Carbetocin (Duratocin) Sales Market Share in 2016
Table EMEA Carbetocin (Duratocin) Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Carbetocin (Duratocin) Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Carbetocin (Duratocin) by Region (2012-2017)
Figure EMEA Carbetocin (Duratocin) Revenue Market Share Regions in 2016
Table EMEA Carbetocin (Duratocin) Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Carbetocin (Duratocin) Revenue and Growth Rate (2012-2017)
Table Europe Carbetocin (Duratocin) Sales (K Units) by Type (2012-2017)
Table Europe Carbetocin (Duratocin) Market Share by Type (2012-2017)
Figure Europe Carbetocin (Duratocin) Market Share by Type in 2016
Table Europe Carbetocin (Duratocin) Sales (K Units) by Application (2012-2017)
Table Europe Carbetocin (Duratocin) Market Share by Application (2012-2017)
Figure Europe Carbetocin (Duratocin) Market Share by Application in 2016
Table Europe Carbetocin (Duratocin) Sales (K Units) by Countries (2012-2017)
Table Europe Carbetocin (Duratocin) Sales Market Share by Countries (2012-2017)
Figure Europe Carbetocin (Duratocin) Sales Market Share by Countries (2012-2017)
Figure Europe Carbetocin (Duratocin) Sales Market Share by Countries in 2016
Table Europe Carbetocin (Duratocin) Revenue (Million USD) by Countries (2012-2017)
Table Europe Carbetocin (Duratocin) Revenue Market Share by Countries (2012-2017)
Figure Europe Carbetocin (Duratocin) Revenue Market Share by Countries (2012-2017)
Figure Europe Carbetocin (Duratocin) Revenue Market Share by Countries in 2016
Figure Germany Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure France Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure UK Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Carbetocin (Duratocin) Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Carbetocin (Duratocin) Sales (K Units) by Type (2012-2017)
Table Middle East Carbetocin (Duratocin) Market Share by Type (2012-2017)
Figure Middle East Carbetocin (Duratocin) Market Share by Type (2012-2017)
Table Middle East Carbetocin (Duratocin) Sales (K Units) by Applications (2012-2017)
Table Middle East Carbetocin (Duratocin) Market Share by Applications (2012-2017)
Figure Middle East Carbetocin (Duratocin) Sales Market Share by Application in 2016
Table Middle East Carbetocin (Duratocin) Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Carbetocin (Duratocin) Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Carbetocin (Duratocin) Sales Volume Market Share by Countries in 2016
Table Middle East Carbetocin (Duratocin) Revenue (Million USD) by Countries (2012-2017)
Table Middle East Carbetocin (Duratocin) Revenue Market Share by Countries (2012-2017)
Figure Middle East Carbetocin (Duratocin) Revenue Market Share by Countries (2012-2017)
Figure Middle East Carbetocin (Duratocin) Revenue Market Share by Countries in 2016
Figure Saudi Arabia Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Carbetocin (Duratocin) Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Carbetocin (Duratocin) Sales (K Units) by Type (2012-2017)
Table Africa Carbetocin (Duratocin) Sales Market Share by Type (2012-2017)
Figure Africa Carbetocin (Duratocin) Sales Market Share by Type (2012-2017)
Figure Africa Carbetocin (Duratocin) Sales Market Share by Type in 2016
Table Africa Carbetocin (Duratocin) Sales (K Units) by Application (2012-2017)
Table Africa Carbetocin (Duratocin) Sales Market Share by Application (2012-2017)
Figure Africa Carbetocin (Duratocin) Sales Market Share by Application (2012-2017)
Table Africa Carbetocin (Duratocin) Sales Volume (K Units) by Countries (2012-2017)
Table Africa Carbetocin (Duratocin) Sales Market Share by Countries (2012-2017)
Figure Africa Carbetocin (Duratocin) Sales Market Share by Countries (2012-2017)
Figure Africa Carbetocin (Duratocin) Sales Market Share by Countries in 2016
Table Africa Carbetocin (Duratocin) Revenue (Million USD) by Countries (2012-2017)
Table Africa Carbetocin (Duratocin) Revenue Market Share by Countries (2012-2017)
Figure Africa Carbetocin (Duratocin) Revenue Market Share by Countries (2012-2017)
Figure Africa Carbetocin (Duratocin) Revenue Market Share by Countries in 2016
Figure South Africa Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Table Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Basic Information List
Table Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales Market Share in EMEA (2012-2017)
Figure Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Revenue Market Share in EMEA (2012-2017)
Table Ferring Inc. Carbetocin (Duratocin) Basic Information List
Table Ferring Inc. Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ferring Inc. Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Ferring Inc. Carbetocin (Duratocin) Sales Market Share in EMEA (2012-2017)
Figure Ferring Inc. Carbetocin (Duratocin) Revenue Market Share in EMEA (2012-2017)
Table Polypeptide Laboraries France Carbetocin (Duratocin) Basic Information List
Table Polypeptide Laboraries France Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Polypeptide Laboraries France Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Polypeptide Laboraries France Carbetocin (Duratocin) Sales Market Share in EMEA (2012-2017)
Figure Polypeptide Laboraries France Carbetocin (Duratocin) Revenue Market Share in EMEA (2012-2017)
Table Chemos GmbH & Co. KG Carbetocin (Duratocin) Basic Information List
Table Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales Market Share in EMEA (2012-2017)
Figure Chemos GmbH & Co. KG Carbetocin (Duratocin) Revenue Market Share in EMEA (2012-2017)
Table Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Basic Information List
Table Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales Market Share in EMEA (2012-2017)
Figure Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Revenue Market Share in EMEA (2012-2017)
Table Acinopeptide Co., Ltd. Carbetocin (Duratocin) Basic Information List
Table Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales Market Share in EMEA (2012-2017)
Figure Acinopeptide Co., Ltd. Carbetocin (Duratocin) Revenue Market Share in EMEA (2012-2017)
Table Bachem AG Carbetocin (Duratocin) Basic Information List
Table Bachem AG Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bachem AG Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Bachem AG Carbetocin (Duratocin) Sales Market Share in EMEA (2012-2017)
Figure Bachem AG Carbetocin (Duratocin) Revenue Market Share in EMEA (2012-2017)
Table Clearsynth Canada INC. Carbetocin (Duratocin) Basic Information List
Table Clearsynth Canada INC. Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Clearsynth Canada INC. Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Clearsynth Canada INC. Carbetocin (Duratocin) Sales Market Share in EMEA (2012-2017)
Figure Clearsynth Canada INC. Carbetocin (Duratocin) Revenue Market Share in EMEA (2012-2017)
Table Leap Labchem Co., Ltd Carbetocin (Duratocin) Basic Information List
Table Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales Market Share in EMEA (2012-2017)
Figure Leap Labchem Co., Ltd Carbetocin (Duratocin) Revenue Market Share in EMEA (2012-2017)
Table Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Basic Information List
Table Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales (K Units) and Growth Rate (2012-2017)
Figure Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales Market Share in EMEA (2012-2017)
Figure Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Revenue Market Share in EMEA (2012-2017)
Table Acinopeptide Co., Ltd. Carbetocin (Duratocin) Basic Information List
Table BOC Sciences Carbetocin (Duratocin) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Carbetocin (Duratocin)
Figure Manufacturing Process Analysis of Carbetocin (Duratocin)
Figure Carbetocin (Duratocin) Industrial Chain Analysis
Table Raw Materials Sources of Carbetocin (Duratocin) Major Manufacturers in 2016
Table Major Buyers of Carbetocin (Duratocin)
Table Distributors/Traders List
Figure EMEA Carbetocin (Duratocin) Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Carbetocin (Duratocin) Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Carbetocin (Duratocin) Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Carbetocin (Duratocin) Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Carbetocin (Duratocin) Sales Market Share Forecast by Region (2017-2022)
Table EMEA Carbetocin (Duratocin) Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Carbetocin (Duratocin) Revenue Market Share Forecast by Region (2017-2022)
Table Europe Carbetocin (Duratocin) Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Carbetocin (Duratocin) Sales Market Share Forecast by Countries (2017-2022)
Table Europe Carbetocin (Duratocin) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Carbetocin (Duratocin) Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Carbetocin (Duratocin) Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Carbetocin (Duratocin) Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Carbetocin (Duratocin) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Carbetocin (Duratocin) Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Carbetocin (Duratocin) Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Carbetocin (Duratocin) Sales Market Share Forecast by Countries (2017-2022)
Table Africa Carbetocin (Duratocin) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Carbetocin (Duratocin) Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Carbetocin (Duratocin) Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Carbetocin (Duratocin) Sales Market Share Forecast by Type (2017-2022)
Table EMEA Carbetocin (Duratocin) Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Carbetocin (Duratocin) Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources